SimonManthaMDMPH

Blood Banking & Transfusion Medicine, Clotting Disorder

Associate Attending

Overview of Dr. Mantha

I am a clinical hematologist with special interests in cancer-associated disorders of hemostasis, genomics, big data and machine learning. My recent work includes an assessment of cancer-specific genetic alterations modulating the risk of thromboembolism, and application of this knowledge to predict clinical events using random survival forests. In the last year I have also developed CEDARS, a simple and efficient pipeline for electronic health record annotation.

Office
530 East 74th Street
New York, NY 10021
Book by Phone+1(719) 299-3610

Education & Training

Harvard UniversityMPH, Public Health, 2010
Yale-New Haven Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2005 - 2006
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2002 - 2005
Laval UnivClass of 1999

Certifications & Licensure

FL State Medical License 2022 - Present
CT State Medical License 2024 - 2025
NJ State Medical License 2018 - 2025
NY State Medical License 2012 - 2025
MA State Medical License 2006 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

126 citations
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
Simon Mantha, Rebecca Karp, V Raghavan, Norma Terrin, Kenneth A. Bauer
BMJ. 2012-08-07
346 citations
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Kelly L. Bolton, Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin
Nature Genetics. 2020-10-26
32 citations
Treatment of central venous catheter-associated deep venous thrombosis in cancer patients with rivaroxaban.
Eva S. Laube, Simon Mantha, Patrick Samedy, Jonathan Wills, Stephen Harnicar
American Journal of Hematology. 2017-01-01

Abstracts/Posters

Extended Mutational Profiling By MSK-IMPACTTM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor MalignancyClinically Relevant Abstract
Simon Mantha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Hypofibrinogenemia and Disseminated Intravascular Coagulation Rarely Complicate Treatment-Naive Acute Lymphoblastic Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018